VIM and breast cancer: Further analysis of the identity of the CD45+/vimentin+ population that we have shown, as well as comparison of T and B cell populations surrounding lobules and ducts in HMD and LMD samples, may reveal further differences in the immune microenvironment that affects BC risk, as has been described previously [111].